Skip to content
GLP-1 Scorecard
Menu
Graded #15

Gala Health

A compounded tirzepatide and semaglutide program for women that reaches all 50 states and keeps a brand-name Ozempic path open — but its $179 and $149 headline rates are yearly-subscription prices, not monthly ones.

Visit Gala Health ↗We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
Not disclosed
Tirzepatide
$179/mo (yearly subscription)
Coverage
All 50 states
Brand-name
Yes

Line Gala Health up against its closest alternatives.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value84/100
Dose & formulation83/100
Clinical oversight85/100
Labs & monitoring83/100
Fulfillment88/100
Contract terms66/100

Strengths

  • Low compounded entry if you prepay the year — $179/mo tirzepatide and $149/mo microdose on the yearly subscription, $199/mo on a 3-month plan
  • Prices are published openly rather than quiz-gated, with all doses included at the one rate
  • All 50 states and LegitScript-verified, with a brand-name Ozempic path kept open ($1,299)
  • HRT and menopause care available alongside GLP-1

Where it loses points

  • No month-to-month price is published anywhere — the $179 tirzepatide and $149 microdose rates are both yearly subscriptions, and the shortest term Gala names is a 3-month plan at $199/mo
  • Compounded formulations are not FDA-approved
  • Brand-name Ozempic is priced steeply at $1,299
  • No oral or sublingual route offered yet — injection only
  • Newer operator (Gala GLP-1 by AI Coaching Inc) with no named clinicians and no named dispensing pharmacy

Bottom line — Grade B−

Best for: Women prepared to commit to a year up front for nationwide compounded GLP-1, with a brand-name escalation path and HRT/menopause care under one roof.

Ranked #15 of 536 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Visit Gala Health ↗

Closest here

The rankings grading nearest Gala Health — the realistic shortlist.

Effecty#23

Mid-market pricing offset by brand-name access and LegitScript verification, all 50 states.

Found#12

The broadest medication bench in the ranking — compounded, brand-name and oral orforglipron — priced off a membership rather than a sticker.

AmberHealth#25

Round-$100 semaglutide nationwide, though tirzepatide runs $175 and it isn't verified.

PepHaūs#27

Verified and nationwide, but priced in the upper-mid band ($152/$246).

Elara Health and Wellness#29

Low-ish both-molecule pricing ($117/$196), nationwide — but unverified.

Piper#30

Mid-value both-molecule pricing ($135/$199), nationwide, though not verified.

The 19 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect Gala Health's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Gala Health's site. Not medical advice; see our disclosure.

← Back to the scorecard